| 1.31 -0.09 (-6.43%) | 11-12 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 1.63 |
1-year : | 1.97 |
| Resists | First : | 1.4 |
Second : | 1.69 |
| Pivot price | 1.35 |
|||
| Supports | First : | 0.93 |
Second : | 0.77 |
| MAs | MA(5) : | 1.28 |
MA(20) : | 1.34 |
| MA(100) : | 0.99 |
MA(250) : | 0.77 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 50.9 |
D(3) : | 45.4 |
| RSI | RSI(14): 51.4 |
|||
| 52-week | High : | 1.69 | Low : | 0.39 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ PETV ] has closed above bottom band by 37.8%. Bollinger Bands are 81.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 12 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 1.42 - 1.43 | 1.43 - 1.44 |
| Low: | 1.25 - 1.26 | 1.26 - 1.27 |
| Close: | 1.3 - 1.31 | 1.31 - 1.32 |
PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.
Fri, 07 Nov 2025
PetVivo Sets Fiscal Second Quarter 2026 Conference Call for Friday, November 14, 2025 at 5:00 p.m. ET - Yahoo Finance
Wed, 05 Nov 2025
New to The Street Signs PetVivo Holdings Inc. (OTCQX:PETV) to a 12-Month National Media Campaign - aberdeennews.com
Thu, 30 Oct 2025
PetVivo Holdings Appoints Josh Ruben to Board of Directors - TradingView
Tue, 28 Oct 2025
Josh Ruben Joins PetVivo Holdings, Inc. Board of Directors - Nasdaq
Tue, 21 Oct 2025
PetVivo Holdings, Inc. Addresses Veterinary Industry's GEN Z Problem With Breakthrough AI License Agreement - GlobeNewswire
Thu, 16 Oct 2025
PetVivo Animal Health, Inc. Enters Vendor Partner Agreement - GlobeNewswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
OTC
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | -4 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 2e+007 (%) |
| Held by Institutions | 1.514e+007 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.64 |
| Profit Margin | 0 % |
| Operating Margin | -1 % |
| Return on Assets (ttm) | 652 % |
| Return on Equity (ttm) | -204 % |
| Qtrly Rev. Growth | 646.7 % |
| Gross Profit (p.s.) | 7.46 |
| Sales Per Share | 118.42 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | -9.64e+006 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | -2.05 |
| Price to Sales | 0.01 |
| Price to Cash Flow | 0 |
| Dividend | 129100 |
| Forward Dividend | 128080 |
| Dividend Yield | 9854960% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|